- Advertisement -

Agilent Expands Cell Analysis Business with Planned $1.2B BioTek Acquisition

(L-R) Mike McMullen, president & CEO, Agilent Technologies; and Briar Alpert, president & CEO, BioTek Instruments. Agilent Technologies has signaled its intent to move...

Impact of race on biotechnology – Innovators Magazine

Racism is a crime against humanity. The ruthless killing last week of George Floyd in Minnesota is a tragedy that should never have happened,...

Addiction scientists seek to better understand cocaine use disorder: ‘Stimulants are coming back’

Nearly 2 percent of the U.S. population reported cocaine use in 2020, and the highly addictive substance was involved in nearly one in five...

Non-traditional pet owners at increased risk of zoonotic diseases

Contact with non-traditional pets increases the risk of exposure to zoonotic pathogens, which are pathogens that spread between animals and people. The National Association...

Research provides key insights into the molecular underpinnings of acute liver...

In a study published in the journal of Genes & Diseases, a team of researchers from Chonnam National University and the Korea Research Institute...

Study Reveals Hybrid Job Training Boosts Women’s Participation in Nepal

Distance learning programs have become a pivotal tool in reducing barriers to education and vocational training, particularly for women in developing regions. A recent...

ASGCT 2026: AI-Optimized Cas12l Gene Editor Offers Compact Cas9 Alternative

BOSTON — In a potentially significant advance for the genome editing field, researchers from the biotechnology company Caszyme and the Vilnius University Institute of...

Qureight to support Mediar Therapeutics’ Phase 2 trial of MTX-474 in...

Qureight, an end-to-end imaging CRO that provides enterprise-grade imaging and precision endpoints for clinical trials with a focus on lung and heart disease, and...

ASGCT 2026: AI-Optimized Cas12l Gene Editor Offers Compact Cas9 Alternative

BOSTON — In a potentially significant advance for the genome editing field, researchers from the biotechnology company Caszyme and the Vilnius University Institute of...

Qureight to support Mediar Therapeutics’ Phase 2 trial of MTX-474 in diffuse cutaneous Systemic...

Qureight, an end-to-end imaging CRO that provides enterprise-grade imaging and precision endpoints for clinical trials with a focus on lung and heart disease, and...

Visualizing Receptor Transport Within Neurons via Transcytosis

As spindly, elongated cells, neurons must be able to transport proteins and receptors between distant sites in their cell bodies and axons to function...

more new items

ASGCT 2026: AI-Optimized Cas12l Gene Editor Offers Compact Cas9 Alternative

BOSTON — In a potentially significant advance for the genome editing field, researchers from the biotechnology company Caszyme and the Vilnius University Institute of...

Qureight to support Mediar Therapeutics’ Phase 2 trial of MTX-474 in...

Qureight, an end-to-end imaging CRO that provides enterprise-grade imaging and precision endpoints for clinical trials with a focus on lung and heart disease, and...

Visualizing Receptor Transport Within Neurons via Transcytosis

As spindly, elongated cells, neurons must be able to transport proteins and receptors between distant sites in their cell bodies and axons to function...